Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

● According to Refinitiv, the company's ESG score for its industry is good.


Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.

● The company shows low valuation levels, with an enterprise value at 0.73 times its sales.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● This company will be of major interest to investors in search of a high dividend stock.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For the past twelve months, EPS forecast has been revised upwards.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.


Weaknesses

● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.

● The average consensus view of analysts covering the stock has deteriorated over the past four months.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.